• IN3 ASSESSMENT OF KNOWLEDGE ABOUT TUBERCULOSIS AMONG LIBYAN POPULATION IN NORTH EAST LIBYA

    Nov 1, 2010, 00:00

  • PIH11 IDENTIFYING COST-EFFECTIVE TREATMENT WITH RALOXIFENE IN POSTMENOPAUSAL WOMEN USING RISK ALGORITHMS FOR FRACTURES AND INVASIVE BREAST CANCER

    Nov 1, 2010, 00:00

  • PIH36 ASSISTED REPRODUCTIVE TECHNOLOGIES- A HEALTH TECHNOLOGY ASSESSMENT PERSPECTIVE

    Nov 1, 2010, 00:00

  • PHP27 USING COLLABORATIVE PROGRAM BETWEEN PHARMACISTS AND NURSES YO IMPROVE SPONTANEOUS ADVERSE DRUG REACTION REPORTING SYSTEM IN THAILAND

    Nov 1, 2010, 00:00

  • PIH16 SURGICAL REPAIR OF ANTERIOR VAGINAL WALL PROLAPSE USING PROLIFT AND COLPORRHAPHY. A COST-EFFECTIVENESS ANALYSIS FOR A THIRD LEVEL HOSPITAL IN MEXICO

    Nov 1, 2010, 00:00

  • PND47 APPLICATION OF THE KANO METHODOLOGY FOR EVALUATING MIGRAINE TREATMENT EXPECTATIONS AMONG PATIENTS TREATED BY NEUROLOGISTS IN SPAIN-THE MIGREXX STUDY

    Nov 1, 2010, 00:00

  • PCN142 WHAT IS THE CURRENT RD LANDSCAPE FOR METASTATIC BREAST CANCER? AN INVESTIGATION INTO RECENT CLINICAL TRIAL ACTIVITY

    Nov 1, 2010, 00:00

  • PDB10 LOWER EXTREMITY AMPUTATION PREVENTION (LEAP) IN SINGAPORE- ECONOMIC ANALYSIS OF RESULTS

    Nov 1, 2010, 00:00

  • PCN100 COST-EFFECTIVENESS OF GEFITINIB VERSUS DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN

    Nov 1, 2010, 00:00

  • PGI30 ASSESSMENT OF FEASIBILITY OF THE METHODOLOGICAL APPROACH DESCRIBED IN THE MODEL FOR THE REGULATION OF REIMBURSEMENT PRICES IN GERMANY

    Nov 1, 2010, 00:00

  • PDB1 HYPOGLYCEMIA-RELATED HEALTH-CARE UTILIZATION FOLLOWING INITIATION OF INSULIN ASPART IN A VIAL/SYRINGE OR IN A PREFILLED DISPOSABLE PEN (FLEXPEN).ANALYSIS OF REAL-WORLD UTILIZATION IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PSY8 ACCESS TO CARE AND HEALTH OUTCOMES AMONG THE SEVERE HEMOPHILIA A POPULATION IN CHINA TODAY

    Nov 1, 2010, 00:00

  • PHP131 THE USE OF ECONOMIC EVALUATION IN A MEDICAL DEVICE COMMISION OF AN ITALIAN TEACHING HOSPITAL

    Nov 1, 2010, 00:00

  • PCV45 COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN VERSUS ATORVASTATIN IN TURKEY- AN ANALYSIS BASED ON THE SYSTEMATIC REVIEW OF PUBLISHED RANDOMIZED CLINICAL TRIALS (RCTS)

    Nov 1, 2010, 00:00

  • PRS48 COMPARISON OF ECONOMETRIC MODELS FOR ESTIMATING COST DIFFERENCES- OLS, GAMMA, AND QUANTILE REGRESSION

    Nov 1, 2010, 00:00

  • PCV53 THE BURDEN OF ISCHEMIC HEART DISEASES AT A MAJOR CARDIAC CENTER IN RIYADH, SAUDI ARABIA

    Nov 1, 2010, 00:00

  • PMS10 HEALTH-CARE UTILIZATION OF NEW PATIENTS WITH LOW BACK PAIN IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PCV38 UTILIZATION, PRICE, AND EXPENDITURE TRENDS FOR ANGIOTENSIN RECEPTOR BLOCKERS IN THE MEDICAID PROGRAM

    Nov 1, 2010, 00:00

  • DB1 EVALUATING THE COST-EFFECTIVENESS OF THERAPY CONVERSION FROM BASAL INSULIN TO BIPHASIC INSULIN ASPART 30/70 IN PATIENTS WITH TYPE 2 DIABETES IN CHINA- A MODELING STUDY OF LONG-TERM COSTS AND HEALTH OUTCOMES

    Nov 1, 2010, 00:00

  • PSY3 CLINICAL AND ECONOMIC OUTCOMES OF ZICONOTIDE NEUROMODULATION IN ITALIAN CANCER PATIENTS

    Nov 1, 2010, 00:00

  • PCV55 HEALTH CARE UTILIZATION AFTER PLATELET AGGREGATION INHIBITORS

    Nov 1, 2010, 00:00

  • PHP56 SERVICES FOR WHICH PHARMACISTS MAY LEVY A FEE- PHARMACIST INITIATED THERAPY (PIT)

    Nov 1, 2010, 00:00

  • PMS1 THE LONG-TERM UTILIZATION AND SAFETY OF BIOLOGICAL AGENTS IN TREATING RHEUMATOID ARTHRITIS PATIENTS-A POPULATION-BASED CASE STUDY IN SOUTHERN TAIWAN

    Nov 1, 2010, 00:00

  • PCV119 SURVEY AT RETAIL PHARMACIES LEVEL ASSESSING QUALITY OF LIFE OF VKAS PATIENTS

    Nov 1, 2010, 00:00

  • PCV135 CREATING AN EFFICIENT HOSPITAL PAYMENT SYSTEM

    Nov 1, 2010, 00:00

  • PUK5 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS IN RENAL REPLACEMENT THERAPY IN SO PAULO, BRAZIL

    Nov 1, 2010, 00:00

  • PMS64 CONSUMPTION OF BISPHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS

    Nov 1, 2010, 00:00

  • PMH30 ECONOMIC EVALUATION OF AGOMELATINE IN MAJOR DEPRESSIVE DISORDERS IN IRELAND

    Nov 1, 2010, 00:00

  • PRS44 EFFECTIVENESS AND EFFICIENCY OF ME-TOO LISTS AS ILLUSTRATED BY THE EXAMPLE OF INTRANASAL STEROIDS

    Nov 1, 2010, 00:00

  • PIH62 ESTIMATING THE CROSS-SECTIONAL NUMBER AND GESTATIONAL AGE DISTRIBUTION OF PREGNANT WOMEN FOR ECONOMIC ANALYSIS

    Nov 1, 2010, 00:00

  • PCV68 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO RECLASSIFY PATIENTS WITH AN INTERMEDIATE RISK BASED ON THE FRAMINGHAM RISK SCORE INTO A LOWER OR HIGHER CATEGORY TO OPTIMIZE STATIN THERAPY

    Nov 1, 2010, 00:00

  • PR3 THE IMPACT OF FINNISH PHARMACEUTICAL PRICING SCHEME IN COST-EFFECTIVENESS ANALYSES

    Nov 1, 2010, 00:00

  • PIN36 ECONOMIC EVALUATION OF AZITHROMYCIN COMPARED WITH OTHER ANTIBIOTICS FOR COMMUNITY-ACQUIRED PNEUMONIA AND SINUSITIS TREATMENT

    Nov 1, 2010, 00:00

  • PHP47 EFFICIENCY IN DRUG PRESCRIPTION MEASURED BY THE APPLICATION OF ADJUSTED CLINICAL GROUPS IN THIRTEEN SPANISH PRIMARY CARE CENTRES

    Nov 1, 2010, 00:00

  • PDB27 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS OF DIABETES IN ASIA AND OCEANIA

    Nov 1, 2010, 00:00

  • PCN63 SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SERBIA

    Nov 1, 2010, 00:00

  • PDB40 THE ECONOMIC IMPORTANCE OF 'METABOLIC MEMORY' IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN SWEDEN

    Nov 1, 2010, 00:00

  • PCV47 ASSOCIATION BETWEEN HOSPITAL PROCESS PERFORMANCE AND OUTCOME OF PATIENTS WITH ACUTE MYOCARIDAL INFARCTION

    Nov 1, 2010, 00:00

  • PMH8 EXCESS MORTALITY RISK IN PATIENTS WITH PSYCHOSIS HOSPITALIZED IN JAPANESE NATIONAL MENTAL HOSPITALS

    Nov 1, 2010, 00:00

  • DS3 A COMPARISON OF SIGNAL DETECTION PERFORMANCE BETWEEN REPORTING ODDS RATIO AND BAYESIAN CONFIDENCE PROPAGATION NEURAL NETWORK METHODS ON ADVERSE DRUG REACTION SPONTANEOUS REPORTING DATABASE OF THE THAI FDA

    Nov 1, 2010, 00:00

  • PGI5 EVALUATION OF OCTREOTIDE COST AFTER PHARMACEUTICAL CARE IMPLEMENTATION AT SURGICAL WARD

    Nov 1, 2010, 00:00

  • PMS65 RETROSPECTIVE OBSERVATIONAL DATABASE ANALYSIS OF TNF- INHIBITOR SWITCHING PATTERNS IN PATIENTS IN THE UNITED STATES WITH RHEUMATOID ARTHRITIS IN TWO DISTINCT 'NATURALISTIC' TREATMENT SETTINGS USING A PRE-PROGRAMMED DATA ANALYSIS TOOL

    Nov 1, 2010, 00:00

  • PMH31 THE COST-EFFECTIVENESS OF ARIPIPRAZOLE IN PATIENTS WITH BIPOLAR I DISORDER IN THE UK

    Nov 1, 2010, 00:00

  • PCN46 ECONOMIC EVALUATION OF ONCOTYPE DX TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGENRECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND

    Nov 1, 2010, 00:00

  • PCV13 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS (VTES) IN TOTAL HIP REPLACEMENT (THR) SURGERY

    Nov 1, 2010, 00:00

  • PCV43 OFFSETTING ANNNUAL CARDIOVASCULAR DISEASE-RELATED MEDICAL AND PHARMACY COSTS BETWEEN PATIENTS CONTINUING STATIN MONOTHERAPY OR AUGMENTING STATIN MONOTHERAPY WITH NIACIN EXTENDED-RELEASE

    Nov 1, 2010, 00:00

  • PCV3 COMPARISON OF MORTALITY, HEALTH CARE UTILITY AND COST OF PATIENTS WITH WARFARIN TREATMENT FOR NON-VALVULAR ATRIAL FIBRILLATION VERSUS PATIENTS WITH OTHER TREATMENT

    Nov 1, 2010, 00:00

  • PR2 DECIDING ON VALUE FOR MONEY-A COMPARISON OF THE DUTCH, BELGIAN, SWEDISH, AND FRENCH DRUG REIMBURSEMENT SYSTEMS

    Nov 1, 2010, 00:00

  • PDB32 COST-EFFECTIVENESS CONSEQUENCES OF OBESITY IN T2DM BY INSULIN ANALOGUE THERAPY

    Nov 1, 2010, 00:00

  • PHP82 ASSESSMENT OF PHARMACEUTICAL EXPENDITURE TRENDS IN PORTUGAL-PRICING AND REIMBURSEMENT POLICY

    Nov 1, 2010, 00:00

  • PDB17 GLYCATED HEMOGLOBIN AS A SURROGATE MARKER FOR THE APPEARANCE AND PROGRESSION OF MACRO VASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS- SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PSS13 LINGUISTIC VALIDATION OF THE NATIONAL EYE INSTITUTE- QUALITY OF LIFE QUESTIONNAIRE-42 (NEI-RQL-42) FOR PATIENTS WITH REFRACTIVE ERROR MODIFIED FOR SIMPLIFIED CHINESE IN MAINLAND CHINA AND HINDI IN INDIA

    Nov 1, 2010, 00:00

  • PDB80 A CONTROLLED, PROSPECTIVE LONGITUDINAL, INTERVENTIONAL, NATURALISTIC STUDY TO EVALUATE THE UNIQUE HEALTH CARE PROGRAM 'CONVERSATION MAP' FOR TURKISH PATIENTS WITH TYPE-2 DIABETES IN ONE GERMAN MAJOR CITY

    Nov 1, 2010, 00:00

  • PIH7 BODY COMPOSITION CHANGES IN THE PREOPERATIVE PERIOD AND AFTER SURGERY

    Nov 1, 2010, 00:00

  • PIN14 PUBLIC HEATH AND ECONOMIC IMPACT OF ROTAVIRUS VACCINATION IN KOREA

    Nov 1, 2010, 00:00

  • PCN92 PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF OXALIPLATIN IN PALLIATIVE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER (MCCR)

    Nov 1, 2010, 00:00

  • PIH39 PATIENTS WITH URINARY DISORDERS, EVOCATIVE OF BPH WHAT ARE THEIR EXPECTATIONS?

    Nov 1, 2010, 00:00

  • PND2 WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE

    Nov 1, 2010, 00:00

  • PIH12 GOLD STAGE AND DURATION OF HOSPITAL ADMISSION DETERMINES SIZE AND STRUCTURE OF COPD RELATED DIRECT MEDICAL COSTS IN ELDERLY

    Nov 1, 2010, 00:00

  • PND20 IS ROPINIROLE-PROLONGED RELEASE A COST-SAVING TREATMENT OPTION IN PARKINSONS DISEASE?

    Nov 1, 2010, 00:00

  • PMS67 CONJOINT ANALYSIS OF REDUCTION OF CO-PAYMENT RATE OF NATIONAL HEALTH INSURANCE SYSTEM IN JAPAN

    Nov 1, 2010, 00:00

  • PIN37 HEALTH ECONOMIC EVALUATION OF CONJUGATE PNEUMOCOCCAL VACCINES IN LATIN AMERICAN COUNTRIES

    Nov 1, 2010, 00:00

  • PIH33 PSYCHOMETRIC VALIDATION OF AN ABBREVIATED VERSION OF THE SEXUAL FUNCTION QUESTIONNAIRE (ASFQ)

    Nov 1, 2010, 00:00

  • PHP124 DESCRIPTION OF THE PRICING AND REIMBURSEMENT SYSTEM IN THE CZECH REPUBLIC

    Nov 1, 2010, 00:00

  • PIN11 COSTS OF QUANTIFERON TB-GOLD VERSUS TUBERCULIN SKIN TEST IN SPANISH HEALTH CARE WORKERS

    Nov 1, 2010, 00:00

  • PCN116 ANALYSIS OF THE EQ-5D QUESTIONNAIRE FOR PATIENTS WITH ADVANCED HER2-POSITIVE GASTRIC CANCER (HER2 AGC) BASED ON THE TRASTUZUMAB FOR GASTRIC CANCER (TOGA) STUDY

    Nov 1, 2010, 00:00

  • PCN7 ESTIMATION ON THE INCIDENCE OF SELECTED CANCERS IN CHINA, 2004

    Nov 1, 2010, 00:00

  • PCN134 DEALING WITH CULTURALLY SENSITIVE QUESTIONS IN THE COURSE OF TRANSLATING EORTC QUALITY-OF-LIFE GROUP QUESTIONNAIRES

    Nov 1, 2010, 00:00

  • PCN146 HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES

    Nov 1, 2010, 00:00

  • PDB86 HEALTH TECHNOLOGY ASSESSMENT OF DIABETES COMPOUNDS- THE POLISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • PCV5 ASSESSMENT OF LIPID ABNORMALITIES- PREVALENCE AND ATTAINMENT OF LIPID GOALS/NORMAL LEVELS AMONG ADULTS IN THAILAND

    Nov 1, 2010, 00:00

  • PDB8 COST-EFFECTIVENESS OF SWITCHING PATIENTS EITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING- A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

    Nov 1, 2010, 00:00

  • PIH4 COMPARING THE MODEL PREDICTED VACCINE IMPACT AGAINST ROTAVIRUS HOSPITALIZATION WITH OBSERVED DATA IN BELGIUM

    Nov 1, 2010, 00:00

  • PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA

    Nov 1, 2010, 00:00

  • PRS47 USE OF PROPENSITY SCORE MATCHING, STANDARD REGRESSION ANALYSIS AND INSTRUMENTAL VARIABLE METHOD IN OUTCOMES RESEARCH STUDIES- A COMPARATIVE ANALYSIS

    Nov 1, 2010, 00:00

  • PMC23 PROPOSED METHODS FOR CONDUCTING SENSITIVITY ANALYSES ON THRESHOLD-DERIVED ESTIMATES OF VALUE-BASED PRICE AND PRODUCT PROFILES FOR EARLY-STAGE DRUGS

    Nov 1, 2010, 00:00

  • PHP93 DOES THE PACKAGE DESIGN MATTER? THE INFLUENCE OF OTC PACKAGE DESIGN ON PATIENTS DRUG KNOWLEDGE

    Nov 1, 2010, 00:00

  • PUK31 PSYCHOMETRIC VALIDATION OF THE SPANISH VERSION OF THE OVERACTIVE BLADDER QUESTIONNAIRE SHORT-FORM (OABQ-SF) TO ASSESS SEVERITY OF SYMPTOMS AND PATIENT HEALTH RELATED QUALITY OF LIFE IN SUBJECTS WITH OVERACTIVE BLADDER

    Nov 1, 2010, 00:00

  • PCV83 PILOTING THE DEVELOPMENT OF A COST-EFFECTIVE EVIDENCEINFORMED CLINICAL PATHWAY- MANAGING HYPERTENSION IN JORDANIAN PRIMARY CARE

    Nov 1, 2010, 00:00

  • PCN161 DECISION-ANALYTIC MODELING IN CHRONIC MYELOID LEUKEMIA-A SYSTEMATIC OVERVIEW

    Nov 1, 2010, 00:00

  • PHP35 HEALTH TECHNOLOGY ASSESSMENTS- INDICATORS OF DEVELOPMENT IN ASIA

    Nov 1, 2010, 00:00

  • PCV12 COMPARATIVE EFFICACY OF EZETIMIBE-STATIN COMBINATION THERAPY AND STATIN MONOTHERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA- SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMISED CONTROLLED TRIALS

    Nov 1, 2010, 00:00

  • PCV25 RISK OF STROKE AND PREVENTATIVE STEPS AMONG PATIENTS DIAGNOSED WITH ATRIAL FIBRILLATION IN EUROPE

    Nov 1, 2010, 00:00

  • PCN17 ECONOMIC EVALUATION OF PEMETREXED IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN

    Nov 1, 2010, 00:00

  • PIN12 COST-OF-ILLNESS OF CHRONIC HEPATITIS B INFECTION IN VIETNAM

    Nov 1, 2010, 00:00

  • PIN11 COST ANALYSIS OF ADVERSE DRUG EVENTS GROM GPO-VIRS AND GPO-VIRZ IN PEOPLE LIVING WITH HIV/AIDS IN THAILAND

    Nov 1, 2010, 00:00

  • PMS22 ECONOMIC BURDEN OF OSTEOPOROSIS-RELATED FRACTURE HOSPITALIZATIONS IN FRANCE

    Nov 1, 2010, 00:00

  • PIH21 IS ROUTINE IMMUNIZATION OF ELDERLY WITH THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE LIKELY TO BE CONSIDERED AS COST-EFFECTIVE?

    Nov 1, 2010, 00:00

  • PMC4 CHOOSING THE RIGHT DISTRIBUTION WHEN PERFORMING PROBABILISTIC SENSITIVITY ANALYSIS- RELATIVE RISKS AND THE TRIANGULAR DISTRIBUTION A SIMULATION STUDY

    Nov 1, 2010, 00:00

  • PRS37 ASSOCIATION OF PATIENT-REPORTED INHALER SATISFACTION WITH PHYSICIAN-PERCEIVED COMPLIANCE WITH ASTHMA TREATMENT-RESULTS OF A CROSS-SECTIONAL STUDY IN FIVE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PMS50 PATIENTS STATED HEALTH-OUTCOME PREFERENCES FOR CONFOUNDED PATIENT-REPORTED OUTCOME DOMAINS FOR OSTEOARTHRITIS

    Nov 1, 2010, 00:00

  • PMC4 COST ESTIMATION IN HEALTH ECONOMIC EVALUATIONS IN GERMANY- A SYSTEMATIC REVIEW

    Nov 1, 2010, 00:00

  • PMH6 INCREASING ADMINISTRATIVE PREVALENCE OF ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) IN GERMANY- EVIDENCE FROM NORDBADEN, 2003 TO 2008

    Nov 1, 2010, 00:00

  • PIN66 EVALUATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY IN MAITAMA DISTRICT HOSPITAL, ABUJA NIGERIA

    Nov 1, 2010, 00:00

  • PIN45 COST-EFFECTIVENESS ANALYSIS OF TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B BOTH PLUS RIBAVIRIN IN SPAIN

    Nov 1, 2010, 00:00

  • PIH27 ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE (HRQOL) AMONG NON-PRESCRIPTION MEDICINE CUSTOMERS IN MALAYSIA

    Nov 1, 2010, 00:00

  • PMS23 BURDEN OF ILLNESS OF OSTEOPOROSIS IN AUSTRIA

    Nov 1, 2010, 00:00

  • PMH13 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS FOR PATIENTS WITH A BIPOLAR DIAGNOSIS AT CLINICALLY RECOMMENDED DOSES

    Nov 1, 2010, 00:00

  • PCN101 COST-UTILITY ANALYSIS OF DASATINIB AS A SECOND-LINE TREATMENT IN THE CHRONIC PHASE OF CHRONIC MYELOID LEUKAEMIA IN RUSSIA

    Nov 1, 2010, 00:00

  • PIN26 ENVIRONMENTAL SITUATION OF DROP IN CENTERS FOR HIGH RISK POPULATION ON HIV/AIDS PREVENTION IN DHAKA, BANGLADESH

    Nov 1, 2010, 00:00

  • PMS15 FREQUENCY AND RISK FACTORS OF GOUT FLARES IN A LARGE POPULATION-BASED COHORT OF INCIDENT GOUT

    Nov 1, 2010, 00:00

  • PCN2 ASSESSMENT ON THE DECREASING USE OF NARCOTIC ANALGESICS BY USING CANCER PAIN ADJUVANTS

    Nov 1, 2010, 00:00

  • PCV32 BUDGET IMPACT ANALYSIS OF PACLITAXEL DRUG ELUTING STENT (DES) FOR THE TREATMENT OF LOWER LIMB PERIPHERAL ARTERIAL DISEASE (PAD) IN FRANCE

    Nov 1, 2010, 00:00

  • PHP49 INFLUENCE OF THE CHRONIC DISEASE IN HEALTH RESOURCES USE- ECONOMICS CONSECUENCES AND RISK STRATIFICATION

    Nov 1, 2010, 00:00

  • PMH12 COST-EFFECTIVENESS OF TYPICALS, ATYPICALS AND PSYCHOSOCIAL INTERVENTIONS FOR SCHIZOPHRENIA IN THAILAND

    Nov 1, 2010, 00:00

  • HE2 NEW DRUGS AND THE GROWTH OF HEALTH EXPENDITURE- EVIDENCE FROM DIABETIC PATIENTS IN TAIWAN

    Nov 1, 2010, 00:00

  • PSY24 COST OF CARE FOR CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS EXPERIENCING RESISTANCE AND/OR INTOLERANCE TO IMATINIB FROM THE PUBLIC HEALTH SYSTEM PERSPECTIVE IN MEXICO

    Nov 1, 2010, 00:00

  • PSY44 COST-EFFECTIVENESS OF A LIDOCAINE PLASTER RELATIVE TO GABAPENTIN AND PREGABALIN IN THE TREATMENT OF POSTHERPETIC NEURALGIA IN SPAIN

    Nov 1, 2010, 00:00

  • PHP48 ECONOMIC EVALUATION OF HEALTH CARE INTERVENTIONS DURING MORE THAN 25 YEARS IN SPAIN (1983-2008)

    Nov 1, 2010, 00:00

  • PCN123 DEVELOPMENT OF A COMPUTER-ADAPTIVE PATIENT REPORTED OUTCOME TOOL FOR THE SCREENING FOR PSYCHO-ONCOLOGICAL TREATMENT NEEDS

    Nov 1, 2010, 00:00

  • PHP105 HOW CAN THE USE OF PREDICTIVE BIOMARKERS LEAD TO POSITIVE HTA RECOMMENDATIONS?

    Nov 1, 2010, 00:00

  • PHP3 THE VALUE OF PATIENT PERSPECTIVES IN THE DRUG DEVELOPMENT LIFECYCLE

    Nov 1, 2010, 00:00

  • PDB30 USE OF MEDICAL INFORMATION SYSTEM FOR ASSESSMENT OF THE COST OF THERAPY OF DIABETIC FOOT PATIENTS IN RUSSIA

    Nov 1, 2010, 00:00

  • PCV36 BUDGET IMPACT MODEL OF VENOUS THROMBOEMBOLISM PREVENTION AFTER TOTAL HIP AND KNEE REPLACEMENT

    Nov 1, 2010, 00:00

  • PCV121 A SURVEY OF PHYSICIANS ATTITUDES TOWARD THE CONTROL OF CARDIOVASCULAR RISK FACTORS. THE EURIKA STUDY.

    Nov 1, 2010, 00:00

  • PCV2 SUCCESSFUL IMPLEMENTATION OF A PT APPROVED THERAPEUTIC INTERCHANGE PROGRAM OF ANGIOTENSIN II RECEPTOR BLOCKERS IN A MEDICAL CENTER IN TAIWAN

    Nov 1, 2010, 00:00

  • PMH49 ANTIDEPRESSANT UTILIZATION, ADHERENCE AND HEALTH CARE SPENDING IN THE UNITED STATES-THE CASE OF MDD PATIENTS 2000-2007

    Nov 1, 2010, 00:00

  • PMS55 ANALYSIS ON THE POSSIBLE ASSOCIATION BETWEEN RHEUMATOID ARTHIRITIS AND DIABETES MELLITUS TYPE 2

    Nov 1, 2010, 00:00

  • PCN32 COMPARING FORECASTED WITH ACTUAL BUDGET IMPACT- REIMBURSED CANCER DRUGS IN THE NETHERLANDS

    Nov 1, 2010, 00:00

  • NI1 RETROSPECTIVE ANALYSIS OF TECHNOLOGY APPRAISALS CONDUCTED BY UKS NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN SEVERAL CANCER INDICATIONS- HIGHER EVIDENCE BARRIERS FOR TARGETED THERAPIES?

    Nov 1, 2010, 00:00

  • PCV101 THE IMPACT OF MEDICATION SWITCHES INDUCES BY MEDICATION DISCOUNT CONTRACTS ON CHRONIC PATIENTS ADHERENCE

    Nov 1, 2010, 00:00

  • PUK1 CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING COMPUTED TOMOGRAPHY- A COMPARATIVE SAFETY META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Nov 1, 2010, 00:00

  • PMH55 THE SUBJECTIVE WELL-BEING UNDER NEUROLEPTIC SCALE SHORT FORM (SWN-K20) AND THE SF-36 AS QUALITY OF LIFE MEASURES IN SCHIZOPHRENIC PATIENTS

    Nov 1, 2010, 00:00

  • PMH71 THE APPLICABILITY OF THE QALY AS EFFECT MEASURE IN CRIMINAL YOUTHS

    Nov 1, 2010, 00:00

  • PMH4 LABOR FORCE WITHDRAWAL OF PATIENTS WITH PSYCHIATRIC ILLNESS IN TAIWAN

    Nov 1, 2010, 00:00

  • MT3 COMPARATIVE EFFECTIVENESS OF ANTIDEPRESSANTS (AD) IN THE TREATMENT OF THE ELDERLY WITH MAJOR DEPRESSIVE DISORDER (MDD)-A MIXED TREATMENT COMPARISON AND META-REGRESSION ANALYSIS

    Nov 1, 2010, 00:00

  • MT4 MIXED TREATMENT COMPARISON (MTC) OF ANTIFUNGAL DRUGS FOR PROPHYLAXIS TREATMENT AGAINST INVASIVE FUNGAL INFECTIONS (IFIS) IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL MALIGNANCIES OR ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANT ...

    Nov 1, 2010, 00:00

  • PCV137 A SYSTEMATIC REVIEW ON DISEASE BURDEN AND UNMET NEEDS FOR VENOUS THROMBOEMBOLISM IN HOSPITALISED MEDICAL PATIENTS IN EUROPE SHOWS UNDER-UTILIZATION OF PREVENTIVE THERAPIES

    Nov 1, 2010, 00:00

  • PIH25 THE IMPACT OF EMPLOYEES WORK ABSENTEEISM DUE TO CARE FOR A SICK PERSON ON PRODUCTIVITY IN POLAND

    Nov 1, 2010, 00:00

  • PND36 HEALTH STATUS COMPARISON BETWEEN STABLE PARKINSONS DISEASE PATIENTS AND THOSE EXPERIENCING OFF-TIME

    Nov 1, 2010, 00:00

  • PHP85 ASSESSING PUBLIC ACCOUNTABILITY OF KOREAN DRUG REIMBURSEMENT DECISION PROCESS

    Nov 1, 2010, 00:00

  • PIN68 EFFECT OF THE ANTIBIOTICS USE MONITORING PROGRAM FOR THE ACUTE UPPER-RESPIRATORY INFECTIONS DISEASE IN KOREAN CLINICS

    Nov 1, 2010, 00:00

  • PMC7 TRANSLATING ITEM BANKS- BENEFITS AND CHALLENGES

    Nov 1, 2010, 00:00

  • PRS33 ECONOMIC EVALUATION OF ILOPROST, EPOPROSTENOL AND TREPROSTINIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • AD3 A CONCEPTUAL FRAMEWORK THAT CAPTURES THE MULTIDIMENSIONAL ASPECT OF ADHERENCE IN A HEALTHECONOMIC MODEL- AN APPLICATION IN CHRONIC NONMALIGNANT PAIN MANAGEMENT

    Nov 1, 2010, 00:00

  • PMS78 WORSE 6-MONTH BASELINE HAQ AND THE SELF-REPORTED RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX PREDICT IMPROVEMENT IN THEIR SCORES 6 MONTHS LATER, AMONG RHEUMATOID ARTHRITIS PATIENTS

    Nov 1, 2010, 00:00

  • PCN60 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH ADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH EARLY STAGE OPERABLE BREAST CANCER

    Nov 1, 2010, 00:00

  • PCN3 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING EVENTS BY CHEMOTHERAPY EMETOGENICITY IN PATIENTS WITH CANCER TREATED IN A HOSPITAL OUTPATIENT SETTING

    Nov 1, 2010, 00:00

  • PRS2 CARESS-THE CANADIAN REGISTRY OF SYNAGIS (2006-2009)

    Nov 1, 2010, 00:00

  • PCN62 SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SLOVAKIA

    Nov 1, 2010, 00:00

  • PIN75 ESTIMATION OF PATIENTS WITH ANTIRETROVIRAL THERAPY POTENTIALLY USED FOR HIV PREVENTION (POST-EXPOSURE PROPHYLAXIS, MOTHER-TO-CHILD TRANSMISSION PROPHYLAXIS) IN GERMANY

    Nov 1, 2010, 00:00

  • PCN4 CANCER SYMPTOM SURVEY AND RELIABILITY ANALYSIS

    Nov 1, 2010, 00:00

  • PMH21 SOCIETAL COSTS OF BIPOLAR DISORDER-THE CASE OF SWEDEN

    Nov 1, 2010, 00:00

  • PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE

    Nov 1, 2010, 00:00

  • PMH32 ECONOMIC EVALUATION OF AGOMELATINE IN MAJOR DEPRESIVE DISORDERS IN HUNGARY

    Nov 1, 2010, 00:00

  • PMS3 IMPROVEMENT IN EFFICACY AND SAFETY OUTCOMES AFTER CERVICAL ARTHROPLASTY VERSUS STANDARD ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF) SURGERIES-A META-ANALYSIS OF PUBLISHED RCTS

    Nov 1, 2010, 00:00

  • PDB53 COST-EFFECTIVENESS OF PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) FOLLOWED IN PRIMARY CARE SETTINGS

    Nov 1, 2010, 00:00

  • PCV100 THE EFFECTS OF DOSING COMPLEXITY ON ADHERENCE WITH PRESCRIPTION MEDICATIONS COMMONLY USED FOR CARDIOVASCULAR PATIENTS

    Nov 1, 2010, 00:00

  • PDB22 EVALUATION OF ANTIDIABETIC UTILIZATION AND PRESCRBING PATTERNS IN TAIWAN DURING 2004 TO 2008

    Nov 1, 2010, 00:00

  • MT1 DOES MODEL CHOICE IN MIXED TREATMENT COMPARISONS AFFECT THE OUTCOME FOR DECISION-MAKERS?

    Nov 1, 2010, 00:00

  • IN4 HERPES ZOSTER-ASSOCIATED ILLNESSES, QUALITY OF LIFE AND HEALTH-CARE COSTS AMONG 180 THAI PATIENTS

    Nov 1, 2010, 00:00

  • PSY6 COST-EFFECTIVENESS OF ORAL TRIPTAN THERAPY IN KOREA

    Nov 1, 2010, 00:00

  • PIN9 ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN JAPAN USING A TRANSMISSION DYNAMIC MODEL

    Nov 1, 2010, 00:00

  • PMC5 DEVELOPMENT OF A WEB-BASED SOFTWARE TOOL TO EVALUATE THE ECONOMIC IMPACT OF LOST PRODUCTIVITY DUE TO PREMATURE MORTALITY IN DEVELOPED AND EMERGING NATIONS

    Nov 1, 2010, 00:00

  • PMH3 DETERMINANTS OF PSYCHIATRIC HOSPITAL ADMISSION IN SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • PHP29 THE EFFECTS OF NICE APPRAISALS ON PRESCRIBING AND COSTSHARING BEHAVIOR IN THE US

    Nov 1, 2010, 00:00

  • PCN75 COMPARISON OF ADVANCED NONINVASIVE TECHNIQUES TO SCREEN COLORECTAL CANCER- FECAL IMMUNOCHEMICAL TEST VS. FECAL DNA; A COS-EFFECTIVENESS STUDY

    Nov 1, 2010, 00:00

  • PHP52 HIGH AND INTENSIVE UTILIZERS IN HEALTH CARE-A STRATEGIC CHALLENGE FOR MEDICAL SUPPLY IN THE COMPULSORY HEALTH INSURANCE

    Nov 1, 2010, 00:00

  • PCV9 RATE OF SUBSEQUENT CORONARY EVENTS AND DIRECT ECONOMIC OUTCOMES FOLLOWING AN ACUTE CORONARY EVENT BETWEEN PATIENTS AUGMENTING STATIN TO FURTHER REDUCE LDL-C VS. IMPROVING A COMPREHENSIVE LIPID PROFILE

    Nov 1, 2010, 00:00

  • PCV107 VALUATION OF HEALTH STATE UTILITIES RELATED TO CARDIOVASCULAR PREVENTION WITH ASPIRIN

    Nov 1, 2010, 00:00

  • PMS20 COST AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTH KOREA

    Nov 1, 2010, 00:00

  • PCV60 COST OF ANALYSIS OF THE ADVERSE EFFECTS OF THE ANTIARRYTHMIC DRUGS IN THE CLINCAL PRACTICE IN SPAIN

    Nov 1, 2010, 00:00

  • HE1 A CROSS-COUNTRY COMPRASION OF HEALTH PERFORMANCE BETWEEN TAX-FUNDED AND SOCIAL HEALTH INSURANCE SYSTEM- THE CHANNEL VIA PREVENTIVE CARE

    Nov 1, 2010, 00:00

  • PSY67 PREDICTING EQ-5D UTILITIES FROM NEUROPATHIC PAIN SCORES- COMPARING INDIRECT MAPPING OF PREDICTED ITEM RESPONSES WITH DIRECT MAPPING OF SCORES

    Nov 1, 2010, 00:00

  • PHP117 EMERGENCY NURSES AND PHYSICAL EXAMINATIONS-WHOSE DUTY?

    Nov 1, 2010, 00:00

  • PUK4 LONG-TERM HEALTHCARE RESOURCE CONSUMPTION AMONG HEMODIALYSIS PATIENTS AND PERITONEAL DIALYSIS PATIENTS IN TAIWAN

    Nov 1, 2010, 00:00

  • PGI32 USING DATA ENVELOPMENT ANALYSIS TO ESTABLISH THE EFFECTIVENESS EVALUATION OF DRUGS

    Nov 1, 2010, 00:00

  • PSY9 THE ADMINISTRATION OF LIQUID INTRAVENOUS IMMUNOGLOBULINS IN SPAIN- A BUDGET IMPACT ANALYSIS TO ESTIMATE COSTS DUE TO AN INCREASING PRIVIGEN PENETRATION

    Nov 1, 2010, 00:00

  • PCV6 OUTCOME OF ADVERSE DRUG REACTIONS REGISTERED WITH INTENSIVE MONITORING SYSTEM

    Nov 1, 2010, 00:00

  • PDB24 DIRECT HEALTH CARE COSTS OF DIABETES MELLITUS IN HUNGARY

    Nov 1, 2010, 00:00

  • PGI5 A BUDGET IMPACT ANALYSIS OF THE HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON IN BRAZIL

    Nov 1, 2010, 00:00

  • PCV103 COST IMPLICATION OF UNACCEPTABLE REFILL-BASED ADHERENCE RATES OF ANTIHYPERTENSION TREATMENT IN THE SOUTH AFRICAN PRIVATE HEALTH CARE ENVIRONMENT

    Nov 1, 2010, 00:00

  • PND41 THE IMPACT OF PAIN SEVERITY AND FREQUENCY ON HRQOL IN THE BIG 5 EUROPEAN UNION COUNTRIES

    Nov 1, 2010, 00:00

  • PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND

    Nov 1, 2010, 00:00

  • MA3 GLAUCOMA DISEASE PROGRESSION STATES- ESTABLISHING A DIRECT, QUANTITATIVE LINK BETWEEN VISUAL FIELD DEFECTS AND UTILITY LOSS

    Nov 1, 2010, 00:00

  • PHP26 VALIDATION OF ELECTRONIC DATABASE IN COMMUNITY HOSPITALS IN PATIENTS WITH ATRIAL FIBRILLATION

    Nov 1, 2010, 00:00

  • PCV34 DOES BALANCE BILLING RAISE THE CONCERNS ON EQUITY OF HEALTH UNDER A NATIONAL HEALTH INSURANCE PROGRAM IN TAIWAN?

    Nov 1, 2010, 00:00

  • PCV28 CARDIOVASCULAR RISK FACTORS AMONG ASIAN INDIAN AND WHITE ADULTS IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PHP118 PERCEPTION OF PHARMACISTS SALES REPRESENTATIVES BY PHYSICIANS

    Nov 1, 2010, 00:00

  • PMC8 PREDICTING THE SF-6D PREFERENCE-BASED INDEX SCORE USING THE SF-8 HEALTH SURVEY

    Nov 1, 2010, 00:00

  • PCN44 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN

    Nov 1, 2010, 00:00

  • PMS60 TNF THERAPY REDUCES THE ODDS OF WORSENING DISABILITY TRENDS IN RHEUMATOID ARTHRITIS OVER AT LEAST 2 YEARS-DATA FROM THE NDB-PORTUGAL COHORT

    Nov 1, 2010, 00:00

  • DU1 THE IMPACTS OF ABUSE OF ANTIBIOTIC THERAPIES IN CHINA

    Nov 1, 2010, 00:00

  • PMS39 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN COSTA RICA

    Nov 1, 2010, 00:00

  • PIH53 DO HIGH-INCOME GROUPS IN PAKISTAN UNDERSTAND THE CONCEPT OF GENERIC MEDICINES?

    Nov 1, 2010, 00:00

  • PMS75 MODELING OF RHEUMATOID ARTHRITIS- A METHODOLOGICAL APPROACH

    Nov 1, 2010, 00:00

  • PRS8 A COMPARISON OF CLINICAL EFFICACY AND SAFETY OF CICLESONIDE WITH BUDESONIDE IN 1-1 AND 1-2 DOSE RATIOS IN THE TREATEMENT OF BRONCHIAL ASTHMA

    Nov 1, 2010, 00:00

  • PMS54 GAP BETWEEN PATIENT-REPORTED ESTIMATION ON FRACTURE RISK AND THE WHO ASSESSMENT TOOL (FRAX) IN POSTMENOPAUSAL OSTEOPOROSIS

    Nov 1, 2010, 00:00

  • PCN74 ADDING ZOLEDRONIC ACID TO ENDOCRINE THERAPY IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER CAN BE COST-EFFECTIVE FROM ITALIAN, SPANISH, AND PORTUGUESE HEALTH-CARE PERSPECTIVES, BASED ON THE ABCSG-12 TRIAL

    Nov 1, 2010, 00:00

  • PIH54 METFORMIN FOR THE TREATMENT OF CHILDHOOD OBESITY- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PIH5 PHARMACOEPIDEMIOLOGICAL BURDEN OF PREGNANCY IN BELARUS

    Nov 1, 2010, 00:00

  • PCN148 IMAGING TESTS IN STAGING AND SURVEILLANCE OF EARLY BREAST CANCER (EBC) IN ITALY-CHANGES IN ROUTINE CLINICAL PRACTICE AND COSTS IMPLICATIONS

    Nov 1, 2010, 00:00

  • PIH37 DISPENSED MEDICATIONS LABELING IN MALAYSIA-VIEWS FROM GENERAL PUBLIC

    Nov 1, 2010, 00:00

  • PIH20 HEALTH-RELATED QUALITY OF LIFE IN CHINESE CHRONIC PROSTATITIS PATIENTS

    Nov 1, 2010, 00:00

  • PCV17 ESTIMATING COST OF INPATIENT CORONARY ANGIOGRAPHY USING STEP DOWN METHOD AT UNIVERSITY KEBANGSAAN MALAYSIA MEDICAL CENTER

    Nov 1, 2010, 00:00

  • PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES

    Nov 1, 2010, 00:00

  • PMS14 RECURRENT FRACTURES AFTER FIRST HIP FRACTURES AND PREVENTION OF SECOND HIP FRACTURES IN JAPANESE WOMEN

    Nov 1, 2010, 00:00

  • PCV45 MEDICAL MALPRACTICE AND LITIGATION-WHAT DOES THIS MEAN FOR THE COST-EFFECTIVENESS OF DIAGNOSING CHEST PAIN?

    Nov 1, 2010, 00:00

  • PCV15 META-REGRESSION APPROACH TO IDENTIFY THE EQUIVALENCE DOSE RATIOS OF ROSUVASTATIN TO SIMVASTATIN AND ATORVASTATIN

    Nov 1, 2010, 00:00

  • PIH16 CONTENT AND PSYCHOMETRIC VALIDITY OF THE EYELASH SATISFACTION QUESTIONNAIRE (ESQ) IN CHINA

    Nov 1, 2010, 00:00

  • PCV116 QUALITY OF LIFE IN CHRONIC SYMPTOMATIC HEART FAILURE PATIENTS IN SPAIN

    Nov 1, 2010, 00:00

  • PHP102 A SURVEY OF HTA RESEARCH METHODS AND TRENDS IN EUROPE

    Nov 1, 2010, 00:00

  • PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1-98 AND ATAC TRIALS-A UK PERSPECTIVE

    Nov 1, 2010, 00:00

  • PCV78 COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN CHRONIC STABLE ANGINA PATIENTS IN AN AUSTRIAN SETTING

    Nov 1, 2010, 00:00

  • PHP77 DIRECT CONTRACTS ON PATENT-PROTECTED PHARMACEUTICALS IN GERMANY- MOTIVES OF SICK FUNDS AND PHARMACEUTICAL COMPANIES

    Nov 1, 2010, 00:00

  • PIN6 COMPARISON OF SOCIO-DEMOGRAPHIC AND CLINICAL FACTORS OF PULMONARY AND EXTRA PLUMONARY TUBERCULOSIS IN YEMEN

    Nov 1, 2010, 00:00

  • PHP65 VALUE BASED PRICING IN THE UK-A SURVEY-BASED APPROACH

    Nov 1, 2010, 00:00

  • PUK26 THE INFLUENCE OF FUTURE UNRELATED COSTS ON COSTEFFECTIVENESS ESTIMATES-TREATMENT OF HYPERPHOSPHATEMIA WITH LANTHANUM CARBONATE IN PRE-DIALYIS PATIENTS WITH CHRONIC KIDNEY DISEASE

    Nov 1, 2010, 00:00

  • PMS11 LONGITUDINAL ASSESSMENT OF GOUT IN A LARGE SAMPLE OF ITALIAN PATIENTS- PREVALENCE AND DISEASE MANAGEMENT IN GPS OFFICES

    Nov 1, 2010, 00:00

  • PSY49 PATIENTS PREFERENCES IN OVERWEIGHT AND OBESITY THERAPY WITH DISCRETE CHOICE EXPERIMENTS

    Nov 1, 2010, 00:00

  • PRS4 ASSESSMENT OF KNOWLEDGE ABOUT TUBERCULOSIS AMONG TB PATIENTS IN NORTH EAST LIBYA

    Nov 1, 2010, 00:00

  • PIN57 EVALUATION OF MEDICATION ADHERENCE IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY (ART) IN MAITAMA DISTRICT HOSPITAL, ABUJA NIGERIA

    Nov 1, 2010, 00:00

  • PMH20 SWITCHING BETWEEN SSRI BRANDS IN AUSTRALIA

    Nov 1, 2010, 00:00

  • PIH32 EVALUATING THE PERCEPTION OF ACADEMIC PHARMACIST TOWARD THEIR ROLE IN HEALTH-CARE SYSTEM OF PAKISTAN

    Nov 1, 2010, 00:00

  • PSY2 POTENTIAL COST SAVINGS ASSOCIATED WITH FASTER BLEEDING RESOLUTION IN THE INPATIENT TREATMENT OF HEMOPHILIA WITH INHIBITORS

    Nov 1, 2010, 00:00

  • PCN158 TREATMENT DECISION CHANGE WITH 21-GENE RECURRENCE SCORE IN PATIENTS WITH EARLY STAGE BREAST CANCER (ESBC)- A META-ANALYSIS

    Nov 1, 2010, 00:00

  • PUK29 CHARACTERIZING THE RELATIONSHIP BETWEEN HEALTH UTILITY IN KIDNEY TRANSPLANT RECIPIENTS IN UK AND US WITH DIFFERENT LEVELS OF KIDNEY FUNCTION

    Nov 1, 2010, 00:00

  • PHP101 EVALUATION OF ACCEPTANCE AND REJECTION RATES OF ORPHAN DRUGS ACROSS SIX HTA BODIES

    Nov 1, 2010, 00:00

  • PMC22 REVENUE OPTIMIZATION MODEL TO OPTIMISE POSITION AND INDICATION OF NEW LAUNCHES

    Nov 1, 2010, 00:00

  • PSY26 A RETROSPECTIVE STUDY TO EVALUATE THE MORBIDITY PROFILES AND THERAPEUTIC COST OF PATIENTS WITH CHRONIC PAIN IN URBAN AREA

    Nov 1, 2010, 00:00

  • PSY32 THE COST-EFFECTIVENESS OF ELTROMBOPAG FOR THE TREATMENT OF CHRONIC ADULT IMMUNE THROMBOCYTOPENIC PURPURA (ITP) IN IRELAND

    Nov 1, 2010, 00:00

  • PHP14 PHARMACEUTICAL PROCUREMENT AND SUPPLY CHAIN IN PUBLIC AND PRIVATE SECTOR IN DELHI, INDIA

    Nov 1, 2010, 00:00

  • PRS25 A COST-UTILITY ANALYSIS FOR TIOTROPIUM BROMIDE IN THE LONG TERM TREATMENT OF SPECIFIC SUBGROUPS OF ITALIAN COPD PATIENTS

    Nov 1, 2010, 00:00

  • PCN94 CAPECITABINE OXALIPLATIN (FOLFOX4) IN THE ADJUVANT TREATMENT OF PATIENTS WITH COLON CANCER (ACC)- COMPARISON OF DIRECT MEDICAL AND SOCIETAL (INDIRECT) COSTS

    Nov 1, 2010, 00:00

  • HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS- A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY

    Nov 1, 2010, 00:00

  • PMS70 THE MANAGEMENT OF OSTEOARTHRITIS- ECONOMY OF NSAIDS

    Nov 1, 2010, 00:00

  • PDB95 SIMPLIFICATION OF PATIENT LEVEL SIMULATIONS TO COHORT MODEL FOR SCENARIO ANALYSIS

    Nov 1, 2010, 00:00

  • PMH2 EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • PDB84 MANAGEMENT OF ACROMEGALY IN CLINICAL PRACTICE CONDITIONS IN SPAIN

    Nov 1, 2010, 00:00

  • PCV11 EFFECTS OF MEDICATION SUPPLY ON HEALTH-CARE COSTS AND RE-HOSPITALIZATIONS IN PATIENTS WITH CHRONIC HEART FAILURE

    Nov 1, 2010, 00:00

  • PDB85 APPROVAL AFTER REJECTION-AN INSIGHT IN HTA RE-EVALUATIONS

    Nov 1, 2010, 00:00

  • PMC8 BURDEN OF DISEASE AND ECONOMIC EVALUATION- ARE WE INVESTIGATING WHAT IT REALLY MATTERS?

    Nov 1, 2010, 00:00

  • PCN83 A COST-EFFECTIVENESS ANALYSIS (CEA) FOR DENOSUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY FOR CANCER TREATMENTINDUCED BONE LOSS (CTIBL) IN NON-METASTATIC PROSTATE CANCER (PRCA)- A SWEDISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • PHP19 ANALYSIS OF THE GREEK PHARMACEUTICAL MARKET-THE FRAMEWORK, THE FACTS AND THE TRENDS (1998-2008)

    Nov 1, 2010, 00:00

  • PDB4 MEDICAL SERVICE COST ASSOCIATED WITH PIOGLITAZONE AND SULFONYLUREA TREATMENT AMONG TYPE 2 DIABETIC PATIENTS ENROLLED IN A US INTEGRATED HEALTH-CARE SYSTEM

    Nov 1, 2010, 00:00

  • PRS51 ADVANCED PATTERN RECOGNITION METHODS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS SUFFERING FROM ALLERGIC RHINITIS

    Nov 1, 2010, 00:00

  • PCN121 CONFIRMATION OF BRIEF PAIN INVENTORY SHORT FORM (BPI-SF) 'WORST PAIN' ITEM CUT-POINT FOR THE ASSESSMENT OF PAIN PROGRESSION IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

    Nov 1, 2010, 00:00

  • PIN3 PRESCRIBER INFLUENCE ON THE PREVALENCE OF POTENTIAL ANTIRETROVIRAL DRUG-DRUG INTERACTIONS ON PRESCRIPTIONS IN SOUTH AFRICA

    Nov 1, 2010, 00:00

  • PCV33 THE IMPACT OF SWITCHING PATIENTS TO ROSUVASTATIN ON HEALTH-CARE EXPENDITURE AND PREVENTION OF CARDIOVASCULAR DISEASE- A COHORT STUDY

    Nov 1, 2010, 00:00

  • PHP76 ALLOCATION OF A SINGLE BUDGET FOR HEALTH CARE, PROFESSIONAL EDUCATION, AND RESEARCH

    Nov 1, 2010, 00:00

  • PCN34 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LIVER CANCER TREATMENT IN KOREA

    Nov 1, 2010, 00:00

  • PSS2 USE OF INCREASED DOSAGES OF BIOLOGICS IN PLAQUE PSORIASIS AND POTENTIAL SAVINGS BY TREATING HIGH-DOSE PATIENTS WITH USTEKINUMAB INSTEAD-A BUDGET IMPACT MODEL

    Nov 1, 2010, 00:00

  • PCV128 MODELING OF HEALTH SERVICE RESEARCH RESULTS WITH UPDATED COST DATA-THE GERSHWIN STUDY EXAMPLE

    Nov 1, 2010, 00:00

  • PGI4 PREVALENCE AND INCIDENCE OF HEPATITIS A IN A UNITED STATES MANAGED CARE CLAIMS DATABASE

    Nov 1, 2010, 00:00

  • PSS4 COST-OF-ILLNESS IN PATIENTS WITH CHRONIC HAND ECZEMA- RESULTS FROM A MULTI-CENTRE STUDY IN GERMANY

    Nov 1, 2010, 00:00

  • PND43 IMPACT OF MEMANTINE TREATMENT INITIATION ON PSYCHOTROPICS USE- ANALYSES WITH THE RAMQ DATABASE

    Nov 1, 2010, 00:00

  • RS3 THE BAYESIAN APPROACH FOR PERFORMANCE-BASED PRICING-A CASE STUDY IN JAPAN

    Nov 1, 2010, 00:00

  • PHP9 PUBLIC PREFERENCES TOWARD ORAL SOLID DOSAGE FORMS

    Nov 1, 2010, 00:00

  • PND12 EUROPEAN-HUNTINGTONS DISEASE BURDEN STUDY (EURO-HDB)-PRELIMINARY RESULTS FOR ITALY AND FRANCE

    Nov 1, 2010, 00:00

  • PCV108 METHODS FOR ESTIMATING HEALTH-STATE UTILITIES IN PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • PDB12 TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS-A PROPENSITY SCORE APPROACH

    Nov 1, 2010, 00:00

  • PCV34 BUDGET IMPACT ANALYSIS OF PRIMARY TREATMENT OF HYPERTENSION WITH CANDESARTAN/HYDROCHLOROTHIAZIDE OR LOSARTAN/HYDROCHLOROTHIAZIDE IN THE MEXICAN SOCIAL SECURITY INSTITUTE

    Nov 1, 2010, 00:00

  • PSS12 ECONOMIC EVALUATION OF RANIBIZUMAB IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN GREECE

    Nov 1, 2010, 00:00

  • PUK33 TEST-RETEST RELIABILITY AND ACCLIMATION EFFECT OF PATIENT PERCEPTION OF INTENSITY OF URGENCY SCALE (PPIUS) FOR OVERACTIVE BLADDER

    Nov 1, 2010, 00:00

  • PND27 COST UTILITY ANALYSIS OF ORPHAN DRUGS- CASE STUDY OF DUODENAL LEVODOPA INFUSION VERSUS STANDARD TREATMENT IN PATIENTS WITH ADVANCED PARKINSONS DISEASE IN SWEDEN

    Nov 1, 2010, 00:00

  • MA2 ESTIMATING THE ASSOCIATION BETWEEN SF-12 RESPONSES TO EQ-5D UTILITY VALUES USING A RESPONSE MAPPING AND A PARAMETER UNCERTAINTY APPROACH

    Nov 1, 2010, 00:00

  • PND10 LONG-TERM DISABILIY COST IN TUBEROUS SCLEROSIS COMPLEX (TSC) IN BRAZIL

    Nov 1, 2010, 00:00

  • PSY40 COST-EFFECTIVENESS OF PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH NEUROPATIC PAIN FOLLOWED IN PRIMARY CARE SETTINGS

    Nov 1, 2010, 00:00

  • PCN28 UTILIZATION OF ANTIEMETIC PROPHYLAXIS ALONGSIDE CHEMOTHERAPY IN FOUR EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PMH64 HEALTH CARE ORGANIZATIONS/SERVICES CLUSTERING- EXAMPLE OF PCTS IN ENGLAND

    Nov 1, 2010, 00:00

  • PHP89 PERCEPTION OF PHARMACO-EPIDEMIOLOGICAL STUDIES BY PHYSICIANS AND MOTIVATION TO PARTICIPATE- FRENCH SITUATION

    Nov 1, 2010, 00:00

  • PHP22 UNIT COST OF BURMESE TRANSLATOR ACTIVITIES IN PHARMACY DEPARTMENT, SAMUTSAKHON HOSPITAL

    Nov 1, 2010, 00:00

  • PMH63 ANTIPSYCHOTIC PRESCRIBING TO THE ELDERLY-A TWO-YEAR COMPARATIVE ANALYSIS

    Nov 1, 2010, 00:00

  • PCN31 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LUNG CANCER TREATMENT IN KOREA

    Nov 1, 2010, 00:00

  • PCN108 SOCIETAL COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED TREATMENT IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN ITALY

    Nov 1, 2010, 00:00

  • PCN82 RESEARCH PRIORITIZATION FOR PROSPECTIVE COMPARATIVE EFFECTIVENESS RESEARCH (CER) IN CANCER GENOMICS

    Nov 1, 2010, 00:00

  • PCV42 CLINICAL OUTCOMES FROM PHARMACIST-MANAGED ANTICOAGULATION CLINICS (ACC) IN PRIMARY CARE SETTINGS IN SINGAPORE

    Nov 1, 2010, 00:00

  • DB2 TRANSLATION AND VALIDATION OF MICHIGAN DIABETES KNOWLEDGE SCALE INTO MALAYSIAN VERSION

    Nov 1, 2010, 00:00

  • PSY7 AN ECONOMIC EVALUATION OF RECOMBINANT ACTIVATED FACTOR VIIA ROOM TEMPERATURE STABLE IN THE MANAGEMENT OF HEMOPHILIA PATIENTS WITH INHIBITORS IN SERBIA

    Nov 1, 2010, 00:00

  • PR1 THE APPLICATION OF PHARMACOECONOMIC MODELING TO ESTIMATE A VALUE-BASED PRICE FOR NEW CANCER DRUGS IN A PUBLICLY FUNDED HEALTH-CARE SYSTEM

    Nov 1, 2010, 00:00

  • PMC49 THE ROLE OF PATIENT-REPORTED OUTCOMES (PRO) AS PRIMARY ENDPOINTS IN THE EVALUATION OF MEDICINES APPROVED WITH PRO CLAIMS

    Nov 1, 2010, 00:00

  • PIH15 ECONOMIC EVALUATION OF DARBEPOETIN ALFA (ARANESP) COMPARED TO EPOETIN ALFA (ERYPO) AND EPOETIN BETA (NEORECORMON) IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA (CIA) IN AUSTRIA

    Nov 1, 2010, 00:00

  • PRS11 A CASE STUDY EVALUATING MALAYSIAN COMMUNITY PHARMACISTS PROFESSIONAL PRACTICES AND SERVICES

    Nov 1, 2010, 00:00

  • PMH37 COST-EFFECTIVENESS OF ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR SCHIZOPHRENIA-THE SPANISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • IR3 THE USE OF IRT MODELING TO ACCOUNT FOR DIFFERENTIAL ITEM FUNCTIONING IN THE PROQOL-HIV QUESTIONNAIRE

    Nov 1, 2010, 00:00

  • PHP2 THE HTA PUZZLE-VALUES, PRIORITIES, TECHNOLOGY AFFORDABILITY, AND PATIENT AND COMMUNITY PREFERENCES. HOW CAN WE MAKE IT LL FIT TOGETHER?

    Nov 1, 2010, 00:00

  • PIN14 COST-OF-ILLNESS OF CANDIDEMIA IN KOREA

    Nov 1, 2010, 00:00

  • PCV98 IMPACT OF MEDICATION ADHERENCE ON HEALTH CARE EXPENDITURES BY MEDICARE BENEFICIARIES WITH HEART FAILURE

    Nov 1, 2010, 00:00

  • PSS12 PSYCHOMETRIC EVALUATION OF MYOPIA-SPECIFIC INSTRUMENTS USED TO ASSESS HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS RECEIVING LASIK SURGERY

    Nov 1, 2010, 00:00

  • PHP110 PHYSICIANS VIEWS OF THE RELATIVE IMPORTANCE OF SELECTED MEDICAL INNOVATIONS ON THE GREEK POPULATION HEALTH STATUS

    Nov 1, 2010, 00:00

  • PIN70 COST EQUITY ANALYSIS OF MALARIA MANAGEMENT-A PILOT STUDY IN THE AFRICAN SETTING

    Nov 1, 2010, 00:00

  • ME4 DEVELOPMENT OF STANDARD COST LIST FOR ECONOMIC EVALUATION IN THAILAND

    Nov 1, 2010, 00:00

  • PMH33 ADJUNCTIVE ANTIPSYCHOTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN TURKEY-A HEALTH ECONOMIC PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMH20 IMPACT AND COSTS OF HOSPITALIZATION IN SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • VA4 COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS B IMMUNIZATION IN VIETNAM- APPLICATION OF COST-EFFECTIVENESS AFFORDABILITY CURVES IN HEALTH DECISION-MAKING

    Nov 1, 2010, 00:00

  • PDB15 WEIGHT CHANGE FOR PATIENTS WITH TYPE 2 DIABETES- SECULAR TRENDS AND IMPACT OF DIFFERENT COMBINATIONS OF THERAPY

    Nov 1, 2010, 00:00

  • PUK18 COST-EFFECTIVENESS ANALYSIS OF TIMELY VERSUS LATE DIALYSIS REFERRAL AFTER RENAL TRANSPLANT FAILURE IN SPAIN

    Nov 1, 2010, 00:00

  • PRS21 BURDEN OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RUSSIA

    Nov 1, 2010, 00:00

  • PSY22 INDIRECT COSTS OF OBESITY IN POLAND

    Nov 1, 2010, 00:00

  • PDB21 COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR

    Nov 1, 2010, 00:00

  • PIN27 AZITHROMYCIN OBSERVATIONAL STUDY IN BACTERIAL UPPER RESPIRATORY TRACT INFECTIONS IN INDIAN PATIENTS

    Nov 1, 2010, 00:00

  • PCN113 TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY)- A RETROSPECTIVE LONGITUDINAL SURVEY

    Nov 1, 2010, 00:00

  • BL4 COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR ANKYLOSING SPONDYLITIS- FIRST RESULTS OF A DISCRETE EVENT SIMULATION MODEL

    Nov 1, 2010, 00:00

  • PHP114 DERIVING DOCTORS PRESCRIBING PATTERNS FROM HEALTH CARE CLAIMS- AN INSTRUMENTAL VARIABLE ANALYSIS

    Nov 1, 2010, 00:00

  • PIN74 PARENTS DILEMMA WHETHER OR NOT TO VACCINATE THEIR CHILDREN AGAINST INFLUENZA A (H1N1)

    Nov 1, 2010, 00:00

  • PIN32 ECONOMIC IMPACT OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE (PHID-CV) IN A COHORT OF NEWBORN IN HONG KONG

    Nov 1, 2010, 00:00

  • PHP27 COMPARISON OF THE USE OF PRESCRIBED MEDICATIONS BETWEEN QUEBEC RESIDENTS COVERED BY PUBLIC AND PRIVATE DRUG INSURANCE-THE REMED REGISTRY

    Nov 1, 2010, 00:00

  • PMS41 THE IMPACT OF MEDICATION ADHERENCE ON THE COST OF OSTEOPOROSIS FRACTURES IN GERMANY- A MODELLING APPROACH

    Nov 1, 2010, 00:00

  • BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND

    Nov 1, 2010, 00:00

  • PMC60 INCLUSION OF CONFERENCE ABSTRACT DATA IN SYSTEMATIC REVIEWS OF PHARMACOLOGIC INTERVENTIONS IN DIFFERENT DISEASE AREAS

    Nov 1, 2010, 00:00

  • CE1 COST-EFFECTIVENESS ANALYSIS OF GLUCOSAMINE SULPHATE FOR THE TREATMENT OF OSTEOARTHRITIS IN THAILAND

    Nov 1, 2010, 00:00

  • PRS23 COMPARISON OF DIFFERENT METHODS FOR ASSESSING ATTRIBUTABLE COSTS-A CASE OF MEDICAL COSTS ATTRIBUTABLE TO OBESE IN PATIENTS WITH ASTHMA

    Nov 1, 2010, 00:00

  • PRS39 QUALITY OF LIFE, PRODUCTIVITY LOSS, AND RESOURCE USE AMONG EMPLOYED ADULTS AGED 40 TO 64 YEARS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UNITED STATES (US) WORKFORCE

    Nov 1, 2010, 00:00

  • PDB6 THE DISEASE BURDEN ANALYSIS OF 295 INPATIENTS WITH DIABETES MELLITUS FROM TONGJI HOSPITAL IN CHINA

    Nov 1, 2010, 00:00

  • CN2 A SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT CHEMOTHERAPY FOR STAGE III COLON CANCER

    Nov 1, 2010, 00:00

  • PDB19 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF TYPE 2 DIABETES IN MEXICAN POPULATION AT PEMEX

    Nov 1, 2010, 00:00

  • PDB17 EVALUATING THE CHOICE OF PEN VERSUS SYRINGE- IMPLICATIONS FOR LONG-TERM DIABETES MANAGEMENT

    Nov 1, 2010, 00:00

  • PMH11 COST-EFFECTIVENESS ANALYSIS FOR PHARMACOLOGICAL INTERVENTION AND COGNITIVE BEHAVIORAL TREATMENT (CBT) FOR MAJOR DEPRESSION IN THAILAND

    Nov 1, 2010, 00:00

  • PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

    Nov 1, 2010, 00:00

  • PHP6 RECOMMENDATIONS FOR A BIOLOGICS-SPECIFIC PRICING SYSTEM IN CHINA

    Nov 1, 2010, 00:00

  • PCV27 ADHERENCE TO ANTIHYPERTENSIVE MEDICATIONS- A QUALITATIVE STUDY AMONG OUTPATIENTS VISITING PUBLIC HOSPITALS IN THE CITY OF QUETTA, PAKISTAN

    Nov 1, 2010, 00:00

  • PIH49 PRESCRIBING PATTERNS OF SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS AND SELECTIVE SEROTONIN AND NORADRENALINE RE-UPTAKE INHIBITORS IN CHILDREN AND ADOLESCENTS IN A SOUTH AFRICAN PRIVATE PRACTICE SETTING

    Nov 1, 2010, 00:00

  • PMH34 COST-EFFECTIVENESS ANALYSIS OF RISPERIDONE LONG-ACTING INJECTION IN SCHIZOPHRENIA- 24-MONTH DATA FROM CZECH REPUBLIC

    Nov 1, 2010, 00:00

  • PSY16 CHANGES IN SELF-REPORTED PAIN SCORES ASSOCIATED WITH DULOXETINE VERSUS OTHER ANTIDEPRESSANTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN THE UNITED STATES VETERANS AFFAIRS HEALTH CARE NETWORK

    Nov 1, 2010, 00:00

  • PSY10 A BUDGET IMPACT MODEL TO INVESTIGATE POTENTIAL COST SAVINGS ASSOCIATED WITH IMPROVEMENTS IN THE SAFETY PROFILE OF STRONG OPIOID ANALGESICS

    Nov 1, 2010, 00:00

  • PSS19 COST-EFFECTIVENESS OF AGE-RELATED MACULAR DEGENERATION- A MODEL

    Nov 1, 2010, 00:00

  • PIH14 VALIDITY OF EQ-5D AND SF-12 AMONG MALAYSIAN

    Nov 1, 2010, 00:00

  • PMH27 RECENT TRENDS IN PSYCHIATRIC PRESCRIPTION DRUG SPENDING

    Nov 1, 2010, 00:00

  • PHP11 NEW AND IMPROVED- DEFINING INNOVATION FOR HEALTH TECHNOLOGY POLICY

    Nov 1, 2010, 00:00

  • PRS5 EVALUATING SAFETY OUTCOMES OF LONG-ACTING BETA AGONISTS (LABAS) IN PATIENTS WITH ASTHMA

    Nov 1, 2010, 00:00

  • PCN110 RESOURCE UTILIZATION AND DIAGNOSTIC APPROACHES IN NON-SMALL-CELL LUNG CANCER (NSCLC) ACROSS EUROPE- EPICLIN-LUNG STUDY

    Nov 1, 2010, 00:00

  • PHP88 STAKEHOLDER PERCEPTIONS OF CLINICAL DRUG TRIALS

    Nov 1, 2010, 00:00

  • PCN164 THE ECONOMICS OF CHRONIC MYELOGENOUS LEUKEMIA- A COMPARISON OF MODELING APPROACHES

    Nov 1, 2010, 00:00

  • PCV114 ABSENTEISM AND IMPAIRED QUALITY OF LIFE IN CHRONIC VENOUS DISEASE IN ROMANIA

    Nov 1, 2010, 00:00

  • PSY43 ECONOMIC ANALYSIS OF RITUXIMAB IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN PORTUGAL

    Nov 1, 2010, 00:00

  • PMH50 TRENDS IN ANTIDEPRESSANT UTILIZATION, AND ASSOCIATED LABOR MARKET PARTICIPATION AND QUALITY OF LIFE OUTCOMES IN THE UNITED STATES- 2004-2007

    Nov 1, 2010, 00:00

  • PMS11 HEALTH-CARE UTILIZATION OF PATIENTS WITH LOW BACK PAIN IN SOUTH KOREA (2006-2008)

    Nov 1, 2010, 00:00

  • PCN28 TRANSLATION AND VALIDATION OF EORTC QLQ-C30 INTO INDONESIAN VERSION FOR CANCER PATIENTS IN INDONESIA

    Nov 1, 2010, 00:00

  • PUK20 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE VS. SEVELAMER HYDROCHLORIDE IN PATIENTS WITH END-STAGE RENAL DISEASE

    Nov 1, 2010, 00:00

  • PCV126 USE OF PROTON PUMP INHIBITORS (PPIS) IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH CLOPIDOGREL IN GERMANY, FRANCE, AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • PHP125 TRENDS IN UK-BASED PATIENT ACCESS SCHEMES- FINANCIAL-BASED VERSUS OUTCOMES-BASED AGREEMENTS

    Nov 1, 2010, 00:00

  • PHP31 THE COMMERCIAL EFFECTS OF REFORMULATIONS OF EXISTING DRUGS

    Nov 1, 2010, 00:00

  • PDB2 HOSPITALIZATIONS FOR SEVERE HYPOGLYCEMIAS IN PATIENTS WITH DIABETES MELLITUS IN SPAIN

    Nov 1, 2010, 00:00

  • PSY25 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

    Nov 1, 2010, 00:00

  • PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN

    Nov 1, 2010, 00:00

  • PGI27 STRUCTURED MANAGEMENT STRATEGY BASED ON THE GERDQ QUESTIONNAIRE VERSUS USUAL PRIMARY CARE FOR GASTROESOPHAGEAL REFLUX DISEASE- META-ANALYSIS OF FIVE EUROPEAN CLUSTER RANDOMIZED TRIALS

    Nov 1, 2010, 00:00

  • PMS8 COST-EFFECTIVENESS OF RISEDRONATE FOR CORTICOSTEROID INDUCED OSTEOPOROSIS IN AUSTRALIA

    Nov 1, 2010, 00:00

  • PSS6 COST OF ILLNESS OF PSORIASIS-A 1-MONTH PROSPECTIVE STUDY IN SOUTHERN SWEDEN

    Nov 1, 2010, 00:00

  • PHP28 IMPACT OF SAFETY ISSUESS BUDGET

    Nov 1, 2010, 00:00

  • PCV94 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO STRATIFY PATIENTS INDICATED FOR A CORONARY STENT

    Nov 1, 2010, 00:00

  • PCN8 CLINICAL AND ECONOMIC BURDEN OF TOXICITIES ASSOCIATED WITH MONOCLONAL ANTIBODIES FOR METASTATIC COLORECTAL CANCER (MCRC)

    Nov 1, 2010, 00:00

  • PIH31 THE EFFECTIVENESS OF SOCIAL MARKETING INTERVENTIONS IN REDUCING ALCOHOL CONSUMPTION AMONG CONSTRUCTION WORKERS AND OTHER RESIDENTS IN A COMMUNITY IN BANGKOK, THAILAND

    Nov 1, 2010, 00:00

  • PCV84 ECONOMIC EVALUATION OF IMPLANTABLE LOOP RECORDER IN THE DIAGNOSIS OF SYNCOPE, UPDATE FROM THE SPANISH NATIONAL HEALTH SYSTEM

    Nov 1, 2010, 00:00

  • PMS44 IMPACT OF OBESITY IN WORKING ADULTS WITH ARTHRITIS IN TERMS OF MEDICAL AND PRDUCTIVITY COSTS

    Nov 1, 2010, 00:00

  • PCV104 IMPACT OF POLICY-DRIVEN STATIN SWITCH PROGRAMS ON ADHERENCE AND PERSISTENCE

    Nov 1, 2010, 00:00

  • PGI15 COST-EFFECTIVENESS OF SEROLOGIC TESTING FOR DIAGNOSING CELIAC DISEASE

    Nov 1, 2010, 00:00

  • BL3 A CONCEPTUAL MODEL FOR POMPE DISEASE-THE BACKBONE FOR AN ECONOMIC EVALUATION OF AN ORPHAN DRUG

    Nov 1, 2010, 00:00

  • PIN64 HERPES ZOSTER AND POST-HERPETIC NEURALGIA- CONSIDERATIONS FOR A PROSPECTIVE, CROSS-SECTIONAL, PATIENT REPORTED OUTCOMES STUDY

    Nov 1, 2010, 00:00

  • PCV93 THROMBOPROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT- COST-UTILITY ANALYSIS OF RIVAROXABAN VERSUS ENOXAPARIN IN SLOVAKIA

    Nov 1, 2010, 00:00

  • PCN130 QUALITY OF LIFE, OUTCOMES, AND COSTS IN THE BELGIAN POPULATION RECEIVING 90Y-ZEVALIN FOR NON-HODGKIN LYMPHOMA- A STUDY FOR REIMBURSEMENT REVISION

    Nov 1, 2010, 00:00

  • PMH18 THE EFFECT OF DIAGNOSED, SELF-REPORTED, AND AT-RISK DEPRESSION ON HEALTH-RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY IN JAPAN AND EUROPE

    Nov 1, 2010, 00:00

  • PMH15 REAL-WORLD TREATMENT PATTERNS AND HEALTH CARE RESOURCE UTILIZATION IN GENERALISED ANXIETY DISORDER (GAD)- A RETROSPECTIVE UNITED STATES DATABASE ANALYSIS

    Nov 1, 2010, 00:00

  • PCN3 RANDOMIZED, PLACEBO, CONTROLLED, DOUBLE-BLIND TRIAL OF MELATONIN IN CHOLANGIOCARCINOMA PATIENTS

    Nov 1, 2010, 00:00

  • PRS35 ASSESSING THE COST-EFFECTIVENESS OF BECLOMETHASONE/ FORMOTEROL IN THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SPAIN

    Nov 1, 2010, 00:00

  • PND23 COST-EFFECTIVENESS EVALUATION OF LEVODOPA/CARBIDOPA/ ENTACAPONE IN TREATMENT OF PARKINSON DISEASE

    Nov 1, 2010, 00:00

  • PCV51 THE IMPACT OF ACQUIRED BRAIN DAMAGE IN TERMS OF EPIDEMIOLOGY, ECONOMICS AND LOSS IN QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PCN33 IMPACT BUDGETING IN CROATIA- FULVESTRANT EXAMPLE

    Nov 1, 2010, 00:00

  • PIN25 THE EFFECT OF PUBLIC INFORMATION ABOUT HUMAN PAPILLOMAVIRUS (HPV) VACCINE ON KNOWLEDGE, ATTITUDE AND VACCINATION DECISION AMONG WOMEN IN THAILAND

    Nov 1, 2010, 00:00

  • PHP104 DESIGNING EUROPEAN GUIDELINES FOR HEALTH OUTCOMES AND COST-EFFECTIVENESS ASSESSMENTS-THE ECHOUTCOME EUROPEAN COMMISSION PROJECT

    Nov 1, 2010, 00:00

  • PMC55 SYSTEMATIC REVIEW OF METHODS FOR META-ANALYSIS AND INDIRECT COMPARISON USED IN EXISTING SYSTEMATIC REVIEWS AND HTA REPORTS-RESULTS FROM THE FIRST PART OF EBAYESMET PROJECT

    Nov 1, 2010, 00:00

  • PHP18 LIFETIME DISTRIBUTION OF MEDICAL COST IN KOREA

    Nov 1, 2010, 00:00

  • PMS29 RETROSPECTIVE CHART REVIEW TO ASSESS COSTS RELATED TO OSTEOPOROTIC FRACTURES IN SLOVENIA AND SERBIA

    Nov 1, 2010, 00:00

  • PSY12 REAL-LIFE BUDGET IMPACT (BI) OF PARENTERAL IRON TREATMENT OF IRON DEFICIENCY ANEMIA/SYNDROME (IDA/IDS) IN SWITZERLAND

    Nov 1, 2010, 00:00

  • PCV8 EVALUATION OF CLINICAL AND DIRECT ECONOMIC OUTCOMES FOLLOWING AN ACUTE CORONARY EVENT AMONG PATIENTS WITH SUBOPTIMAL HDL-C OR TRIGLYCERIDES ADMINISTERED EITHER STATIN AND NIACIN EXTENDED-RELEASE OR STATIN MONOTHERAPY

    Nov 1, 2010, 00:00

  • PIH36 PATIENT SATISFACTION WITH FOLLITROPIN ALFA PREFILLED PEN IN WOMEN UNDERGOING OVARIAN STIMULATION- ELABORATION AND VALIDATION OF VENUSF QUESTIONNAIRE

    Nov 1, 2010, 00:00

  • PIH60 ESTIMATING THE CROSS-SECTIONAL NUMBER AND GESTATIONAL AGE AT BIRTH DISTRIBUTION OF INFANTS FOR ECONOMIC AND HEALTH IMPACT ANALYSIS

    Nov 1, 2010, 00:00

  • PCV52 COST OF MANAGING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION TO MANAGED CARE

    Nov 1, 2010, 00:00

  • PIN7 ANTIFUNGAL TREATMENT FOR INVASIVE CANDIDIASIS- SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PMS5 PRIMARY ANTI-TNF FAILURES EXPERIENCE SUPERIOR CLINICAL RESPONSES TO A SECOND ANTI-TNF AGENT THAN SECONDARY FAILURES- ANALYSIS OF THE ALBERTA RHEUMATOID ARTHRITIS BIOLOGICS REGISTRY

    Nov 1, 2010, 00:00

  • PMH21 PHYSICIAN PRESCRIBING PATTERNS IN INNOVATIVE ANTIDEPRESSANTS IN THE UNITED STATES-THE CASE OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER

    Nov 1, 2010, 00:00

  • PUK10 GENERIC AZATHIOPRIN FOR KYDNEY TRANSPLANT PATIENTS-ANALYSIS OF COST SAVINGS

    Nov 1, 2010, 00:00

  • PIN79 IS IT POSSIBLE TO OBTAIN WILLINGNESS-TO-PAY ESTIMATES IN EUROPE? A VALIDITY TEST OF STATED PREFERENCES FOR HEPATITIS-B TREATMENTS

    Nov 1, 2010, 00:00

  • PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN

    Nov 1, 2010, 00:00

  • PCV24 THE IMPACT OF METABOLIC SYNDROME ON QUALITY OF LIFE AND RESOURCE USE IN CHINA AND THE UNITED STATES

    Nov 1, 2010, 00:00

  • PCN162 EXTRAPOLATION IN TRIAL-BASED COST-EFFECTIVENESS MODELING- IN SEARCH OF A STANDARD

    Nov 1, 2010, 00:00

  • MO1 STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMERS DISEASE

    Nov 1, 2010, 00:00

  • PMC53 COMPARISON OF METHODS FOR ITEM GENERATION AND PRETESTING OF FIVE LYMPHOEDEMA-SPECIFIC HEALTH-RELATED QUALITY OF LIFE QUESTIONNAIRES

    Nov 1, 2010, 00:00

  • PMH8 HEALTH-CARE UTILIZATION COSTS AMONG SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE OR RISPERIDONE IN JAPAN

    Nov 1, 2010, 00:00

  • PSS26 REVIEW OF UTILITIES IN ATOPIC DERMATITIS

    Nov 1, 2010, 00:00

  • PSY61 RISK OF SURGICAL PROCEDURES IN THE INFLAMMATORY BOWEL DISEASE. ADMINISTRATIVE DATABASES AS A RESOURCE OF KNOWLEDGE

    Nov 1, 2010, 00:00

  • PCN96 A UK COST-UTILITY ANALYSIS OF PACLITAXEL ALBUMIN COMPARED TO SOLVENT-BASED PACLITAXEL MONOTHERAPY AND DOCETAXEL MONOTHERAPY FOR PRETREATED METASTATIC BREAST CANCER (MBC)

    Nov 1, 2010, 00:00

  • PIN17 IMPACT OF YELLOW FEVER OUTBREAKS IN BRAZIL, 2000-2009

    Nov 1, 2010, 00:00

  • PND34 A PSYCHOMETRIC EVALUATION OF THE REVISED SCOPA DIARY CARD IN PARKINSONS DISEASE PATIENTS

    Nov 1, 2010, 00:00

  • PMS19 THE INTRODUCTION OF A GERMAN ARTHROPLASTY REGISTER- COST SAVINGS FOR THE HEALTH CARE SYSTEM

    Nov 1, 2010, 00:00

  • PND3 A RAPID REVIEW OF ECONOMIC EVALAUTIONS OF DONEPEZIL, RIVASTIGMINE, GALANTAMINE AND MEMANTINE FOR ALZHEIMERS DISEASE (AD)

    Nov 1, 2010, 00:00

  • PCV65 HEALTH ECONOMIC ASSESSMENT OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN THE FAIR-HF TRIAL

    Nov 1, 2010, 00:00

  • PMC6 ASSESSING PRODUCTIVITY AND ACTIVITY IMPAIRMENT DUE TO ILLNESS IN POLAND

    Nov 1, 2010, 00:00

  • PCN7 ASSESSING INTERFERON-ALPHA MONOTHERAPY IN PATIENTS WITH ADVANCE OR METASTATIC RENAL CELL CARCINOMA

    Nov 1, 2010, 00:00

  • PCN25 DID THE UPTAKE OF NEW TREATMENT OPTIONS CHANGE THE TREATMENT STRATEGY IN PATIENTS WITH COLORECTAL CANCER AND PRIMARY NONRESECTABLE METASTASES? THE RESULTS OF LARGE POPULATION-BASED SURVEY IN GERMANY 2006-2007

    Nov 1, 2010, 00:00

  • PSY62 HEALTH TECHNOLOGY ASSESSMENT FOR RARE DISEASES- A MARKOVIAN MODEL FOR FABRY DISEASE (FD) CONSIDERING ENZYME REPLACEMENT THERAPY(ERT)

    Nov 1, 2010, 00:00

  • PHP63 THE ECONOMIC IMPACT OF THE INITIATION OF PRESCRIPTION CONTROL IN THE GREEK SOCIAL SECURITY FUNDS

    Nov 1, 2010, 00:00

  • PCN115 EVALUATION OF SUPPORT SERVICES TO COLORECTAL CANCER PATIENTS IN MEXICO

    Nov 1, 2010, 00:00

  • PCN131 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN CERVICAL CANCER- CLINICAL SIGNIFICANCE AND METHODOLOGICAL ISSUES

    Nov 1, 2010, 00:00

  • PHP122 COMPETITIVENESS OF HUNGARY IN INTERNATIONAL CLINICAL TRIALS

    Nov 1, 2010, 00:00

  • PND29 COST-UTILITY ANALYSIS OF RIZATRIPTAN VERSUS (GENERIC) SUMATRIPTAN IN SWEDEN

    Nov 1, 2010, 00:00

  • PUK13 INCIDENCE AND COST OF HOSPITALIZATIONS FOR ACUTE URINARY RETENTION ATTRIBUTABLE TO BENIGN PROSTATE HYPERPLASIA IN FRANCE

    Nov 1, 2010, 00:00

  • PUK35 PATIENTS WITH BPH- RESULTS AT 6 MONTHS FOLLOWING TREATMENT WITH PHYTOTHERAPY VERSUS OTHER TREATMENTS

    Nov 1, 2010, 00:00

  • PIN60 CLINICAL PROFILE AND ADHERENCE PATTERN OF ANTI-RETROVIRAL THERAPY OF PEOPLE LIVING WITH HIV/AIDS REGISTERED AT DISTRICT ANTI RETROVIRAL THERAPY CENTRE, UDUPI DISTRICT

    Nov 1, 2010, 00:00

  • PCV44 ROLE OF COMMUNITY PHARMACISTS IN HEALTH-RELATED EDUCATION AND COUNSELLING-VIEWS FROM GENERAL PUBLIC IN THE STATE OF PENANG, MALAYSIA

    Nov 1, 2010, 00:00

  • PCV7 SPONTANEOUS REPORTING OF ADVERSE DRUG REACTIONS INVOLVING HOSPITALIZED CARDIAC PATIENTS

    Nov 1, 2010, 00:00
  • «
  • 141
  • 142 (current)
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »